Author

Emily Huschart

Institution: Texas Tech University

Observed institutions: Texas Tech University, University of Michigan, American Society of Hematology, Center for Cancer and Blood Disorders, Michigan Medicine, Phoenix Children's Hospital, University of California Davis Medical Center, The Ohio State University, University of Toledo

ORCID: 0000-0001-6244-7009

Observed ORCID: 0000-0001-6244-7009

OpenAlex ID: A5035277671

Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia

2020 · Emily Huschart, Holly Miller, et al. · Pediatric Hematology and Oncology · 20

The Large Zinc Finger Protein ZAS3 Is a Critical Modulator of Osteoclastogenesis

2011 · Shujun Liu, Francesca Madiai, et al. · PLoS ONE · 12

Efficacy of Azacitidine and Prophylactic Donor Lymphocyte Infusion after HSCT in Pediatric Patients with Acute Myelogenous Leukemia: A Retrospective Pre-Post Study

2023 · Natalie Booth, Lucia Mirea, et al. · Transplantation and Cellular Therapy · 11

Management of Acute Osteomyelitis: A Ten-Year Experience

2016 · Caitlin Helm, Emily Huschart, et al. · Infectious Disease Reports · 9

Assessing Safe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia

2021 · Emily Huschart, Jonathan Ducore, et al. · Journal of Pediatric Hematology/Oncology · 5

Assessing Safe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia

2017 · Emily Huschart, Jong Chung, et al. · Blood

Works count: 6

Citation count: 57

H-index: 5

I10-index: 3